Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $123.0 million.

  • Qiagen's Other Operating Expenses rose 635.61% to $123.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $466.0 million, marking a year-over-year increase of 118.73%. This contributed to the annual value of $466.0 million for FY2025, which is 2627.68% up from last year.
  • Per Qiagen's latest filing, its Other Operating Expenses stood at $123.0 million for Q4 2025, which was up 635.61% from $114.9 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's Other Operating Expenses ranged from a high of $128.2 million in Q4 2022 and a low of $108.1 million during Q1 2025
  • Its 5-year average for Other Operating Expenses is $118.1 million, with a median of $118.2 million in 2023.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 1705.52% in 2021, then plummeted by 627.32% in 2023.
  • Qiagen's Other Operating Expenses (Quarter) stood at $122.7 million in 2021, then increased by 4.47% to $128.2 million in 2022, then decreased by 6.27% to $120.2 million in 2023, then fell by 3.75% to $115.7 million in 2024, then increased by 6.36% to $123.0 million in 2025.
  • Its Other Operating Expenses stands at $123.0 million for Q4 2025, versus $114.9 million for Q3 2025 and $119.9 million for Q2 2025.